At its monthly meeting, EMA's safety committee, the PRAC, started a review of medicines πŸ’Šcontaining #hydroxyprogesterone and issued a reminder on the restrictions in the use of fluoroquinolone #antibiotics.
More information below πŸ‘‡

https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-10-12-may-2023

#SafetyOfMedicines

πŸ¦πŸ”—: https://n.respublicae.eu/EMA_News/status/1657022453464330250

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 - 12 May 2023 European Medicines Agency

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 - 12 May 2023

European Medicines Agency